An assessment of readiness for behaviour change in patients prescribed ocular hypotensive therapy

Gail Schwartz, K. S. Plake, M. A. Mychaskiw

Research output: Contribution to journalArticle

Abstract

Objectives: To compare responses in two patient populations with a questionnaire developed to identify those prescribed ocular hypotensive medication whose adherence may need improvement and who may be ready to change. Methods: The content/face validity of a 62-item, self-administered questionnaire was confirmed by nine glaucoma specialists. Questions concerned demographics, health and medications, use of/problems with medications, and visual function. The questionnaire was administered anonymously to 102 consecutive patients in a glaucoma referral practice ('glaucoma practice') and 100 from a multispecialty ophthalmology practice ('multispecialty practice'). All participants were prescribed ≥1 ocular hypotensive medication and had no previous trabeculectomy. Results: Patients in the glaucoma practice were more likely to be younger, African-American, and better educated (P<0.05 for each). In both, >80% had glaucoma with >60% diagnosed ≥3 years previously. Most (glaucoma, multispecialty: 87, 93%) reported administering drops every day, but more in the multispecialty practice reported administering drops at the same time every day (79, 92%; P<0.05). Number of adherence problems (mean, 1/patient) and adherence scores (mean, 24; possible scale range, 0-25) were similar. Common adherence barriers were falling asleep and forgetting when the regular schedule changed or when travelling. In the glaucoma practice, the number of adherence problems was correlated with adherence score (r=-0.611; P<0.0001) and number of side effects (r=0.349; P<0.0001). Conclusions: Similarities between patient populations limited our ability to compare responses between groups or to propose adherence counselling tailored to specific demographics. Until such recommendations are possible, physicians should incorporate adherence counselling broadly into their practices.

Original languageEnglish (US)
Pages (from-to)1668-1674
Number of pages7
JournalEye
Volume23
Issue number8
DOIs
StatePublished - Aug 1 2009

Fingerprint

Glaucoma
Counseling
Therapeutics
Demography
Trabeculectomy
Aptitude
Medication Adherence
Ophthalmology
Patient Compliance
Reproducibility of Results
African Americans
Population
Appointments and Schedules
Referral and Consultation
Physicians
Health
Surveys and Questionnaires

Keywords

  • Adherence
  • Compliance
  • Glaucoma
  • Ocular hypotensive medication

ASJC Scopus subject areas

  • Ophthalmology

Cite this

An assessment of readiness for behaviour change in patients prescribed ocular hypotensive therapy. / Schwartz, Gail; Plake, K. S.; Mychaskiw, M. A.

In: Eye, Vol. 23, No. 8, 01.08.2009, p. 1668-1674.

Research output: Contribution to journalArticle

Schwartz, Gail ; Plake, K. S. ; Mychaskiw, M. A. / An assessment of readiness for behaviour change in patients prescribed ocular hypotensive therapy. In: Eye. 2009 ; Vol. 23, No. 8. pp. 1668-1674.
@article{850734b0649440718e06b4b6d255f893,
title = "An assessment of readiness for behaviour change in patients prescribed ocular hypotensive therapy",
abstract = "Objectives: To compare responses in two patient populations with a questionnaire developed to identify those prescribed ocular hypotensive medication whose adherence may need improvement and who may be ready to change. Methods: The content/face validity of a 62-item, self-administered questionnaire was confirmed by nine glaucoma specialists. Questions concerned demographics, health and medications, use of/problems with medications, and visual function. The questionnaire was administered anonymously to 102 consecutive patients in a glaucoma referral practice ('glaucoma practice') and 100 from a multispecialty ophthalmology practice ('multispecialty practice'). All participants were prescribed ≥1 ocular hypotensive medication and had no previous trabeculectomy. Results: Patients in the glaucoma practice were more likely to be younger, African-American, and better educated (P<0.05 for each). In both, >80{\%} had glaucoma with >60{\%} diagnosed ≥3 years previously. Most (glaucoma, multispecialty: 87, 93{\%}) reported administering drops every day, but more in the multispecialty practice reported administering drops at the same time every day (79, 92{\%}; P<0.05). Number of adherence problems (mean, 1/patient) and adherence scores (mean, 24; possible scale range, 0-25) were similar. Common adherence barriers were falling asleep and forgetting when the regular schedule changed or when travelling. In the glaucoma practice, the number of adherence problems was correlated with adherence score (r=-0.611; P<0.0001) and number of side effects (r=0.349; P<0.0001). Conclusions: Similarities between patient populations limited our ability to compare responses between groups or to propose adherence counselling tailored to specific demographics. Until such recommendations are possible, physicians should incorporate adherence counselling broadly into their practices.",
keywords = "Adherence, Compliance, Glaucoma, Ocular hypotensive medication",
author = "Gail Schwartz and Plake, {K. S.} and Mychaskiw, {M. A.}",
year = "2009",
month = "8",
day = "1",
doi = "10.1038/eye.2008.337",
language = "English (US)",
volume = "23",
pages = "1668--1674",
journal = "Eye",
issn = "0950-222X",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - An assessment of readiness for behaviour change in patients prescribed ocular hypotensive therapy

AU - Schwartz, Gail

AU - Plake, K. S.

AU - Mychaskiw, M. A.

PY - 2009/8/1

Y1 - 2009/8/1

N2 - Objectives: To compare responses in two patient populations with a questionnaire developed to identify those prescribed ocular hypotensive medication whose adherence may need improvement and who may be ready to change. Methods: The content/face validity of a 62-item, self-administered questionnaire was confirmed by nine glaucoma specialists. Questions concerned demographics, health and medications, use of/problems with medications, and visual function. The questionnaire was administered anonymously to 102 consecutive patients in a glaucoma referral practice ('glaucoma practice') and 100 from a multispecialty ophthalmology practice ('multispecialty practice'). All participants were prescribed ≥1 ocular hypotensive medication and had no previous trabeculectomy. Results: Patients in the glaucoma practice were more likely to be younger, African-American, and better educated (P<0.05 for each). In both, >80% had glaucoma with >60% diagnosed ≥3 years previously. Most (glaucoma, multispecialty: 87, 93%) reported administering drops every day, but more in the multispecialty practice reported administering drops at the same time every day (79, 92%; P<0.05). Number of adherence problems (mean, 1/patient) and adherence scores (mean, 24; possible scale range, 0-25) were similar. Common adherence barriers were falling asleep and forgetting when the regular schedule changed or when travelling. In the glaucoma practice, the number of adherence problems was correlated with adherence score (r=-0.611; P<0.0001) and number of side effects (r=0.349; P<0.0001). Conclusions: Similarities between patient populations limited our ability to compare responses between groups or to propose adherence counselling tailored to specific demographics. Until such recommendations are possible, physicians should incorporate adherence counselling broadly into their practices.

AB - Objectives: To compare responses in two patient populations with a questionnaire developed to identify those prescribed ocular hypotensive medication whose adherence may need improvement and who may be ready to change. Methods: The content/face validity of a 62-item, self-administered questionnaire was confirmed by nine glaucoma specialists. Questions concerned demographics, health and medications, use of/problems with medications, and visual function. The questionnaire was administered anonymously to 102 consecutive patients in a glaucoma referral practice ('glaucoma practice') and 100 from a multispecialty ophthalmology practice ('multispecialty practice'). All participants were prescribed ≥1 ocular hypotensive medication and had no previous trabeculectomy. Results: Patients in the glaucoma practice were more likely to be younger, African-American, and better educated (P<0.05 for each). In both, >80% had glaucoma with >60% diagnosed ≥3 years previously. Most (glaucoma, multispecialty: 87, 93%) reported administering drops every day, but more in the multispecialty practice reported administering drops at the same time every day (79, 92%; P<0.05). Number of adherence problems (mean, 1/patient) and adherence scores (mean, 24; possible scale range, 0-25) were similar. Common adherence barriers were falling asleep and forgetting when the regular schedule changed or when travelling. In the glaucoma practice, the number of adherence problems was correlated with adherence score (r=-0.611; P<0.0001) and number of side effects (r=0.349; P<0.0001). Conclusions: Similarities between patient populations limited our ability to compare responses between groups or to propose adherence counselling tailored to specific demographics. Until such recommendations are possible, physicians should incorporate adherence counselling broadly into their practices.

KW - Adherence

KW - Compliance

KW - Glaucoma

KW - Ocular hypotensive medication

UR - http://www.scopus.com/inward/record.url?scp=69049083739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=69049083739&partnerID=8YFLogxK

U2 - 10.1038/eye.2008.337

DO - 10.1038/eye.2008.337

M3 - Article

C2 - 19011605

AN - SCOPUS:69049083739

VL - 23

SP - 1668

EP - 1674

JO - Eye

JF - Eye

SN - 0950-222X

IS - 8

ER -